Rani Therapeutics Holdings Inc. Class A Common Stock is a pharmaceutical company specializing in developing oral biologic therapies. With their innovative RaniPill™ technology, they aim to revolutionize drug delivery by enabling oral administration of proteins and peptides traditionally given through injections.